Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: Implication for anti-invasive role of HAI-2/PB in glioblastoma cells

International Journal of Cancer

Volumn 93, Issue 3, 2001, Pages 339-345

  Hamasuna, Ryouichi ^a   Kataoka, Hiroaki ^a   Meng, Jing Yan ^a   Itoh, Hiroshi ^a   Moriyama, Takuzou ^a   Wakisaka, Shinichiro ^a   Koono, Masashi ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Glioblastoma; HGF; HGF activator inhibitor type 2; Invasion

Indexed keywords

HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR TYPE 2; PLACENTA PROTEIN; PLACENTAL BIKUNIN; SCATTER FACTOR; SERINE PROTEINASE INHIBITOR; ULINASTATIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GRADING; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; FIBRINOLYSIS; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ASTROCYTOMA; BLOTTING, NORTHERN; BRAIN NEOPLASMS; COLLAGEN; DNA PRIMERS; DRUG COMBINATIONS; FIBRIN; GLIOBLASTOMA; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOBLOTTING; LAMININ; MEMBRANE GLYCOPROTEINS; NEOPLASM INVASIVENESS; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-MET; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; TRANSFECTION; TRYPSIN INHIBITOR, KUNITZ SOYBEAN;

EID: 0035426921     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1349     Document Type: Article

References (26)

1. Molecular and cellular pathology of intrinsic brain tumours
2. Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro
3. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: Evidence for a role in progression of astrocytic tumors
4. Emerging multipotent aspects of hepatocyte growth factor
5. A novel protease obtained from FBS-containing culture supernatant, that processes single chain form hepatocyte growth factor to two chain form in serum-free culture
6. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor
7. Activation of hepatocyte growth factor in the injured tissues in mediated by hepatocyte growth factor activator
8. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma
9. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor
10. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor
11. Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains
12. Characterization of placental bikunin, a novel human serine protease inhibitor
13. Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo
14. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor
15. Met and hepatocyte growth factor/scatter factor expression in human gliomas
16. Scatter factor expression and regulation in human glial tumors
17. The urokinase-type plasminogen activator system in cancer metastasis: A review
18. Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells
19. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP
20. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo
21. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells
22. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression
23. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation
24. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin
25. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signaling in human cells concomitant with induction of the urokinase proteolytic network
26. Up-regulation of urokinase-type plasminogen activator and u-PA receptor by hepatocyte growth factor/scatter factor stimulation in human glioma cells